Table 4 |
||||
|
DAS28: differences between females and males by country |
||||
| Female, mean (SD) |
Male, mean (SD) |
Difference, mean (95% CI) |
Effect sizea (95% CI) |
|
|
|
||||
| Netherlands |
3.07 (1.19) |
3.03 (1.37) |
0.03 (-0.26 to 0.33) |
0.03 (-0.23 to 0.29) |
| Finland |
3.37 (1.35) |
3.01 (1.60) |
0.37 (0.01 to 0.73) |
0.26 (-0.03 to 0.55) |
| USA |
3.59 (1.56) |
2.65 (1.61) |
0.94 (0.54 to 1.35) |
0.60 (0.31 to 0.85) |
| Greece |
3.52 (1.49) |
2.72 (1.37) |
0.79 (0.40 to 1.19) |
0.55 (0.28 to 0.80) |
| Denmark |
3.49 (1.41) |
3.05 (1.53) |
0.44 (0.05 to 0.83) |
0.31 (0.03 to 0.60) |
| Spain |
3.59 (1.38) |
3.33 (1.31) |
0.26 (-0.10 to 0.62) |
0.19 (-0.07 to 0.45) |
| France |
3.69 (1.41) |
3.56 (1.74) |
0.13 (-0.24 to 0.49) |
0.09 (-0.22 to 0.36) |
| Sweden |
3.83 (1.58) |
3.80 (1.62) |
0.04 (-0.40 to 0.48) |
0.02 (-0.24 to 0.30) |
| UK |
4.09 (1.41) |
3.56 (1.34) |
0.53 (-0.04 to 1.11) |
0.39 (-0.05 to 0.74) |
| Ireland |
4.16 (1.51) |
4.03 (1.86) |
0.13 (-0.32 to 0.57) |
0.08 (-0.25 to 0.34) |
| Canada |
4.13 (1.57) |
4.17 (1.88) |
-0.04 (-0.88 to 0.79) |
-0.03 (-0.60 to 0.57) |
| Turkey |
4.16 (1.43) |
4.12 (1.27) |
0.05 (-0.44 to 0.54) |
0.03 (-0.28 to 0.37) |
| Brazil |
4.25 (1.41) |
3.66 (1.52) |
0.59 (-0.25 to 1.42) |
0.42 (-0.20 to 1.08) |
| UAE |
4.33 (1.72) |
3.83 (1.90) |
0.50 (-0.25 to 1.24) |
0.29 (-0.20 to 0.72) |
| Germany |
4.47 (1.63) |
3.84 (1.97) |
0.64 (0.03 to 1.25) |
0.38 (-0.00 to 0.79) |
| Italy |
4.51 (1.24) |
4.38 (1.37) |
0.13 (-0.22 to 0.48) |
0.10 (-0.17 to 0.42) |
| Estonia |
4.70 (1.43) |
4.53 (1.83) |
0.16 (-0.50 to 0.83) |
0.11 (-0.37 to 0.63) |
| Russia |
4.89 (1.46) |
5.33 (0.86) |
-0.44 (-1.40 to 0.51) |
-0.32 (-0.82 to 0.19) |
| Hungary |
5.13 (1.23) |
4.51 (1.24) |
0.61 (0.00 to 1.23) |
0.50 (0.02 to 1.07) |
| Latvia |
5.24 (1.59) |
5.11(1.41) |
0.13 (-0.78 to 1.03) |
0.08 (-0.49 to 0.68) |
| Poland |
5.32 (1.44) |
5.20 (1.43) |
0.12 (-0.22 to 0.45) |
0.08 (-0.15 to 0.32) |
| Argentina |
5.35 (1.68) |
5.36 (1.95) |
-0.02 (-0.76 to 0.72) |
-0.01 (-0.48 to 0.54) |
| Lithuania |
5.49 (1.30) |
5.51 (1.30) |
-0.02 (-0.43 to 0.38) |
-0.02 (-0.34 to 0.30) |
| Serbia |
5.93 (1.30) |
5.93 (0.97) |
-0.01 (-0.78 to 0.77) |
-0.00 (-0.45 to 0.51) |
| Kosovo |
6.08 (0.95) |
5.83 (0.99) |
0.25 (-0.26 to 0.77) |
0.27 (-0.32 to 0.91) |
|
|
||||
| All |
4.30 (1.64) |
3.76 (1.76) |
0.54 (0.43 to 0.65) |
0.33 (0.25 to 0.39) |
|
|
||||
|
aCohen's D with bias-corrected 95% confidence intervals (CIs) from bootstrapping (1,000 replications). DAS28, disease activity score using 28 joint counts; SD, standard deviation; UAE, United Arab Emirates. |
||||
|
Sokka et al. Arthritis Research & Therapy 2009 11:R7 doi:10.1186/ar2591 |
||||
